medigraphic.com
ISSN 2007-932X (Electronic)
Órgano Oficial de Difusión de la Comisión Nacional de Arbitraje Médico

2022, Number S1

<< Back

Rev CONAMED 2022; 27 (S1)

Angio-embolization in invasive placenta

Guerrero AGML, Briones GJC, Serrano LR

Language: Spanish
References: 26
Page: s47-52
PDF size: 96.41 Kb.





REFERENCES

  1. Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018; 218: 75-87.

  2. Mogos MF, Salemi JL, Ashley M, Whiteman VE, Salihu HM. Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-associated costs, 1998-2011. J Matern Fetal Neonatal Med. 2016; 29 (7): 1077-1082.

  3. Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA et al. Maternal morbidity associated with multiple repeat cesarean deliveries. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Obstet Gynecol. 2006; 107: 1226-1232.

  4. Society of Gynecologic Oncology; American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine, Cahill AG, Beigi R, Heine RP, Silver RM et al. Placenta accreta spectrum. Am J Obstet Gynecol. 2018; 219 (6): B2-B16. doi: 10.1016/j.ajog.2018.09.042.

  5. Bowman ZS, Eller AG, Bardsley TR, Greene T, Varner MW, Silver RM. Risk factors for placenta accreta: a large prospective cohort. Am J Perinatol. 2014; 31: 799-804.

  6. Lyell DJ, Faucett AM, Baer RJ, Blumenfeld YJ, Druzin ML, El-Sayed YY et al. Maternal serum markers, characteristics and morbidly adherent placenta in women with previa. J Perinatol. 2015; 35: 570-574.

  7. Eller AG, Bennett MA, Sharshiner M, Masheter C, Soisson AP, Dodson M et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol. 2011; 117: 331-337.

  8. Warshak CR, Ramos GA, Eskander R, Benirschke K, Saenz CC, Kelly TF et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 2010; 115: 65-69.

  9. Comstock CH, Bronsteen RA. The antenatal diagnosis of placenta accreta. BJOG. 2014; 121 (2): 171-181; discussion 181-182.

  10. Salim R, Chulski A, Romano S, Garmi G, Rudin M, Shalev E. Precesarean prophylactic balloon catheters for suspected placenta accreta: a randomized controlled trial. Obstet Gynecol. 2015; 126 (5): 1022-1028.

  11. Duan XH, Wang YL, Hana XW, Chen ZM. Caesarean section combined with temporary aortic balloon occlusion followed by uterine artery embolisation for the management of placenta accreta. Clin Radiol. 2015; 70 (9): 932-937.

  12. Wang MQ, Liu FY, Duan F, Wang ZJ, Song P, Song L. Ovarian artery embolization supplementing hypogastric-uterine artery embolization for control of severe postpartum hemorrhage: report of eight cases. J Vasc Interv Radiol. 2009; 20 (7): 971-976.

  13. Saha PK, Bagga R, Kalra JK, Arora A, Singla R, Suri V et al. An alternate surgical approach to reduce hemorrhage and complications during cesarean hysterectomy for adherent placenta. Eur J Obstet Gynecol Reprod Biol. 2018; 228: 215-220. doi: 10.1016/j.ejogrb.2018.07.004.

  14. Matsuzaki S, Yoshino K, Endo M, Kakigano A, Takiuchi T, Kimura T. Conservative management of placenta percreta. Int J Gynaecol Obstet. 2018; 140 (3): 299-306. doi: 10.1002/ijgo.12411.

  15. Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum hemorrhage. Obstet Gynecol. 2017; 130 (4): e168-e186.

  16. Izbizky G, Meller C, Grasso M, Velazco A, Peralta O, Otaño L et al. Feasibility and safety of prophylactic uterine artery catheterization and embolization in the management of placenta accreta. J Vasc Interv Radiol. 2015; 26 (2): 162-169; quiz 170.

  17. Teixidor Viñas M, Belli AM, Arulkumaran S, Chandraharan E. Prevention of postpartum hemorrhage and hysterectomy in patients with morbidly adherent placenta: a cohort study comparing outcomes before and after introduction of the Triple-P procedure. Ultrasound Obstet Gynecol. 2015; 46 (3): 350-355.

  18. Kaufman C, Tadros A. Endovascular interventions for the morbidly adherent placenta. J Clin Med. 2018; 7 (5): 92. doi: 10.3390/jcm7050092.

  19. Torres MF, Briones GJC. Percretismo placentario con invasión a vejiga y recto. Cirugía y Cirujanos. 2017; 85 (1): 66-69.

  20. Ramoni A, Strobl EM, Tiechl J, Ritter M, Marth C. Conservative management of abnormally invasive placenta: four case reports. Acta Obstetc Gynecol Scand. 2013; 92: 468-471.

  21. Fox KA, Shamshirsaz AA, Carusi D, Secord AA, Lee P, Turan OM et al. Conservative management of morbidly adherent placenta: expert review. Am J Obstet Gynecol. 2015; 213: 755-760.

  22. Clausen C, Lonn L, Langhoff-Roos J. Management of placenta percreta: a review of published cases. Acta Obstet Gynecol Scand. 2014; 93: 138-143.

  23. Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. Cirse quality assurance document and standards for classification of complications: the Cirse classification system. Cardiovasc Intervent Radiol. 2017; 40 (8): 1141-1146.

  24. Shrivastava V, Nageotte M, Major C, Haydon M, Wing D. Case control comparison of cesarean hysterectomy with and without prophylactic placement of intravascular balloon catheters forplacenta accreta. Am J Obstet Gynecol. 2007; 197: 402.e1-5.

  25. Gonsalves M, Belli A. The role of interventional radiology in obstetric hemorrhage. Cardiovasc Intervent Radiol. 2010; 33 (5): 887-895.

  26. Meller CH, Garcia-Monaco RD, Izbizky G, Lamm M, Jaunarena J, Peralta O et al. Non-conservative management of placenta accreta spectrum in the hybrid operating room: a retrospective cohort study. Cardiovasc Intervent Radiol. 2019; 42 (3): 365-370. doi: 10.1007/s00270-018-2113-y.




2020     |     www.medigraphic.com